Q3 EPS Estimates for Procter & Gamble Cut by William Blair

The Procter & Gamble Company (NYSE:PG) – Equities researchers at William Blair lowered their Q3 2025 earnings estimates for shares of Procter & Gamble in a report issued on Monday, November 25th. William Blair analyst J. Andersen now anticipates that the company will post earnings per share of $1.61 for the quarter, down from their previous estimate of $1.62. The consensus estimate for Procter & Gamble’s current full-year earnings is $6.94 per share.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, beating the consensus estimate of $1.90 by $0.03. The business had revenue of $21.74 billion for the quarter, compared to analysts’ expectations of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The firm’s revenue for the quarter was down .6% compared to the same quarter last year. During the same quarter last year, the firm earned $1.83 EPS.

Several other equities analysts have also recently commented on PG. JPMorgan Chase & Co. lifted their target price on shares of Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a research report on Thursday, September 19th. Royal Bank of Canada reissued a “sector perform” rating and set a $164.00 target price on shares of Procter & Gamble in a research report on Monday, October 21st. DA Davidson raised shares of Procter & Gamble from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $160.00 to $209.00 in a report on Monday. Piper Sandler assumed coverage on Procter & Gamble in a report on Tuesday, September 24th. They set a “neutral” rating and a $174.00 price objective on the stock. Finally, Wolfe Research raised Procter & Gamble to a “strong-buy” rating in a report on Friday, August 23rd. Eight equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $180.45.

Procter & Gamble Stock Performance

NYSE PG opened at $179.31 on Tuesday. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The company has a fifty day moving average price of $170.11 and a 200-day moving average price of $168.83. Procter & Gamble has a 1 year low of $142.50 and a 1 year high of $179.46. The firm has a market cap of $422.28 billion, a price-to-earnings ratio of 30.92, a PEG ratio of 3.81 and a beta of 0.42.

Procter & Gamble Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were given a dividend of $1.0065 per share. The ex-dividend date was Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a yield of 2.25%. Procter & Gamble’s payout ratio is 69.31%.

Insiders Place Their Bets

In related news, insider Balaji Purushothaman sold 12,800 shares of the stock in a transaction on Thursday, October 24th. The shares were sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the transaction, the insider now owns 11,566 shares of the company’s stock, valued at approximately $1,954,538.34. This trade represents a 52.53 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Jon R. Moeller sold 7,007 shares of Procter & Gamble stock in a transaction on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total transaction of $1,202,751.55. Following the completion of the transaction, the chief executive officer now owns 269,172 shares in the company, valued at approximately $46,203,373.80. The trade was a 2.54 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 35,233 shares of company stock valued at $6,024,234 over the last 90 days. Insiders own 0.18% of the company’s stock.

Institutional Investors Weigh In On Procter & Gamble

Institutional investors have recently bought and sold shares of the stock. Itau Unibanco Holding S.A. purchased a new position in shares of Procter & Gamble in the second quarter valued at about $28,000. Fairway Wealth LLC bought a new stake in shares of Procter & Gamble in the second quarter worth about $29,000. RPg Family Wealth Advisory LLC purchased a new position in Procter & Gamble during the 3rd quarter valued at about $33,000. POM Investment Strategies LLC bought a new position in Procter & Gamble during the 2nd quarter valued at approximately $34,000. Finally, Quest Partners LLC purchased a new stake in Procter & Gamble in the 2nd quarter worth approximately $36,000. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

Procter & Gamble Company Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.